Cargando…

Correction to: Management of Lung Cancer in the Patient with Interstitial Lung Disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction Notice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166150/ https://www.ncbi.nlm.nih.gov/pubmed/36757285 http://dx.doi.org/10.1093/oncolo/oyad018

Ejemplares similares

Correction: Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
Publicado: (2021)

Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab
Publicado: (2022)

Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Author Correction: Inspiratory Lung Expansion in Patients with Interstitial Lung Disease: CT Histogram Analyses
por: Park, Junghoan, et al.
Publicado: (2019)

Correction: Correlating SFTPC gene variants to interstitial lung disease in Egyptian children
por: Abdel Megeid, Azza K., et al.
Publicado: (2022)

Correction: Learnings from clinical trials in patients with connective tissue disease‑associated interstitial lung disease
por: Higuero Sevilla, Jean Paul, et al.
Publicado: (2023)

Correction to: Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares
por: Chau, Alice S., et al.
Publicado: (2022)

Correction to: Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
por: Fu, Hongyan, et al.
Publicado: (2023)

Management of Lung Cancer in the Patient with Interstitial Lung Disease
por: Frank, Angela J, et al.
Publicado: (2022)

Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease
por: Dsouza, Kevin G., et al.
Publicado: (2023)

Correction to: Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
Publicado: (2023)

CORRECTION
Publicado: (2018)

Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
Publicado: (2023)

Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma
Publicado: (2022)

Correction Notice to Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population
Publicado: (2022)

Correction Notice
Publicado: (2017)

Correction Notice
Publicado: (2017)

Correction Notice
Publicado: (2019)

Correction Notice
Publicado: (2022)

Correction notice
Publicado: (2022)

Correction notice
Publicado: (2022)

Correction to: Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
Publicado: (2022)

Correction to: An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
Publicado: (2022)

Correction to: A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis Associated Interstitial Lung Disease and Bronchiectasis
por: Khan, Tanjila, et al.
Publicado: (2021)

Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world
por: Kaku, Sawako, et al.
Publicado: (2022)

Clinical and pathological characteristics of IgG4-related interstitial lung disease
por: Lv, Xiaoting, et al.
Publicado: (2022)

Correction Notice—The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action
Publicado: (2023)

Correction Notice: Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study
Publicado: (2023)

Correction Notice: Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm
Publicado: (2021)

Managing Fatigue in Patients With Interstitial Lung Disease
por: Kahlmann, Vivienne, et al.
Publicado: (2020)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Correction Notice – Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study
Publicado: (2023)

Correction to: Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel
Publicado: (2022)

Correction Notice: The EHA Research Roadmap: Anemias
Publicado: (2021)

Correction to: BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer
Publicado: (2022)

Correction to: Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018
Publicado: (2022)

Correction Notice: Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threatening Features Within the Early Post-engraftment Phase
Publicado: (2020)

Diagnosis and management of interstitial lung disease
por: Meyer, Keith C
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5r5sna5u4grkp5i7p8960m761h